IP Library Granted Patent US 9,739,765
Granted Patent B2
US 9,739,765 · App. 14/268,997 · Granted Aug 22, 2017

Metal-based covalent viability reagent for single cell analysis

Inventors: Bernd Bodenmiller (Zurich, CH); Erin F. Simonds (Stanford, CA); Harris G. Fienberg (Stanford, CA); Garry P. Nolan (San Francisco, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
G01N33/5005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,739,765
App. No.
14/268,997
Granted
Aug 22, 2017
Kind
B2
Abstract

The present invention provides a robust viability stain for methods utilizing elemental analysis. A population of cells is contacted with an effective dose of a non-chelated biomacromolecule-reactive metal derivative, which selectively crosses the plasma membrane of non-viable cells, and which covalently modifies a biological macromolecule within the cell, for a period of time sufficient to permit entry into non-viable cells. The population of cells is then washed free of unbound viability reagent; and the presence of the metal within the cells is detected, wherein non-viable cells are selectively labeled with the viability reagent.

Claims (22)

1. A method of distinguishing a viable cell from a dead cell, the method comprising;

(a) contacting the cell with a viability agent that is a compound that contains platinum where the platinum is non-chelated and the viability agent is in a concentration effective to react with biomacromolecules in a non-viable cell;

(b) incubating the resultant contacted cell from step (a) for a period of time sufficient to permit entry of the viability reagent into a non-viable cell;

(c) washing the resultant incubated cell from step (b) free of unbound viability reagent; and

(d) performing elemental mass spectrometry-based detection to determine if platinum is present in the resultant washed cell from step (c), wherein a non-viable cell is selectively labeled with platinum relative to a viable cell.

2. The method of claim 1 , wherein the cell is in a heterogeneous population of cells.

3. The method of claim 1 , wherein the platinum content of the viability reagent is a mixture of isotopes.

4. The method of claim 1 , wherein the platinum content of the viability reagent is synthetically enriched for an isotope.

5. The method of claim 1 , wherein the viability reagent covalently reacts with protein in the cell.

6. The method of claim 1 , further comprising analyzing of the cell for additional analytes by elemental or fluorescent detection.

7. The method of claim 1 , wherein the cell is fixed and permeabilized following contacting with the viability reagent.

8. A method of distinguishing a viable cell from a dead cell, the method comprising:

(a) contacting the cell with cisplatin at a concentration effective to react with biomacromolecules in a non-viable cell;

(b) incubating the resultant contacted cell from step (a) for a period of time sufficient to permit entry of the cisplatin into a non-viable cell;

(c) washing the resultant incubated cell from step (b) free of unbound cisplatin; and

(d) performing elemental mass spectrometry-based detection to determine if platinum is present in the resultant washed cell from step (c), wherein a non-viable cell is selectively labeled with platinum relative to a viable cell.

9. The method of claim 8 , wherein the cisplatin is present at a concentration of from about 1 μM to about 250 μM.

10. The method of claim 8 , wherein the cisplatin is present at a concentration of from about 10 μM to about 50 μM.

11. The method of claim 8 , wherein the incubating step is from about 1 to about 30 minutes.

12. The method of claim 8 , wherein the incubating step is from about 1 to about 10 minutes.

13. The method of claim 8 , wherein the detection is performed by inductively coupled plasma mass spectrometry, secondary ion mass spectrometry; thermal ionization mass spectrometry, or atomic absorption mass spectrometry.

14. The method of claim 8 , wherein the detection is performed by mass cytometry.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2014
From: BODENMILLER, BERND; SIMONDS, ERIN F.; FIENBERG, HARRIS G.; NOLAN, GARRY P.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 034075/0122 →
Continuity (2)
Provisional Application 61818725 · May 2, 2013
Related Publication 20140329272A1 · Nov 6, 2014